GLP-1 use during early pregnancy may not increase risk of major adverse outcomes Taking GLP-1s during the first trimester of pregnancy does not appear to substantially increase the risk of adverse outcomes, according to a new study led by Harvard T.H
Patients dealing with chronic pain conditions such as fibromyalgia often explore peptide therapy as part of a broader recovery plan
The communication warned patients, healthcare providers and compounders about reports of adverse events, overdoses and drug errors involving injectable compounded semaglutide
References: Filippatos, T
Standard Oral Glutathione This is the classic versionfound in capsules, tablets, and powders
Semaglutide the active ingredient in Ozempic and Wegovy mimics GLP-1, a hormone the body naturally produces after eating